Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.98 USD | +1.16% | +1.60% | -4.64% |
Financials (USD)
Sales 2024 * | 23.95M | Sales 2025 * | 72.18M | Capitalization | 296M |
---|---|---|---|---|---|
Net income 2024 * | -76M | Net income 2025 * | -39M | EV / Sales 2024 * | 12.4 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 4.1 x |
P/E ratio 2024 * |
-4.5
x | P/E ratio 2025 * |
-8.84
x | Employees | 100 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 43.45% |
Latest transcript on Verrica Pharmaceuticals Inc.
1 day | +1.16% | ||
1 week | +1.60% | ||
Current month | +17.91% | ||
1 month | +47.26% | ||
3 months | +18.10% | ||
6 months | +97.18% | ||
Current year | -4.64% |
Managers | Title | Age | Since |
---|---|---|---|
Ted White
CEO | Chief Executive Officer | 59 | 17-11-30 |
Terence Kohler
DFI | Director of Finance/CFO | 46 | 21-07-15 |
Compliance Officer | 60 | 18-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Prygocki
BRD | Director/Board Member | 58 | 18-04-30 |
Paul Manning
CHM | Chairman | 68 | 15-11-30 |
Craig Ballaron
BRD | Director/Board Member | 63 | 19-06-12 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.00% | 34 M€ | +1.25% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 6.98 | +1.16% | 125,739 |
24-04-18 | 6.9 | -2.27% | 202,527 |
24-04-17 | 7.06 | +0.86% | 105,357 |
24-04-16 | 7 | +1.16% | 89,905 |
24-04-15 | 6.92 | +0.73% | 163,836 |
Delayed Quote Nasdaq, April 19, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.64% | 296M | |
+24.60% | 654B | |
+24.08% | 552B | |
-5.63% | 356B | |
+15.37% | 319B | |
+7.38% | 295B | |
+3.26% | 211B | |
+0.78% | 206B | |
-9.69% | 147B | |
-6.63% | 144B |
- Stock Market
- Equities
- VRCA Stock